Mari NAGAI, MD, MPH, PhD

 As of Octorver 2023

Deputy director, Division of Partnership Development,
Department of Global Network and Partnership

Area of expertise

Health system strengthening especially human resource for health to achieve universal health coverage, Reproductive, maternal and newborn health, Global health

Fellow of the Japanese Society of Internal Medicine

Message

Mari Nagai has over 25 years of experience in global health in Pacific, Asia, Middle East and African countries including conflict and post-conflict area. Throughout her career Dr Nagai has worked to improve access to health care for vulnerable, isolated populations and those marginalized either socially or geographically because she believes in the rights of everyone to health.

Long-term overseas experiences

International committee membership

Awards

• Delta Omega Honorary Society in Public Health, Alpha Chapter
• Fulbright scholar
• JAIH Young Professional Award

Publication list

■Journal articles

1. Thandar M, Obaidur R Md , Haruyama R , Matsuoka S, Okawa S, Moriyama J, Yokobori Y, Matsubara C, Nagai M, Ota E ,Baba T: Effectiveness of infection control teams in reducing healthcare-associated infections: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health ;2022;19:17075
2. Honda M, Inoue N, Liverani M, et Nagai M: Lessons learned from the history of postgraduate medical training in Japan:from disease‑centred care to patient‑centred care in an aging society. Human Resources for Health; 2022;20:54
3. T Kitamura, H Obara, M　Honda, T Mori, T Ito, M Nagai, S Rattana, T Rathavy, Y Sugiura. : Early essential newborn care in national tertiary hospitals in Cambodia and Lao People’s Democratic Republic: a cross‑sectional study. BMC Pregnancy and Childbirth 2022; 22:745
4. A. D Weeks, O.I.Akinola, M. Amorim, B. Carvalho, C. Deneux-Tharaux, T. Liabsuetrakul, M. Meremikwu, S. Miller, A. Nabhan, M.Nagai, H. Wahabi, D.Walker.: World Health Organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage. Obstet Gynecol. 2022;139(3):458-462.
5. Fujita M, Matsuoka S, Kiyohara H, Nagai M, Hachiya M, Fujita N et al: “Staying at home” to tackle COVID-19 pandemic: Rhetoric or Reality? Cross-cutting analysis of nine population groups vulnerable to homelessness in Japan. Tropical Medicine and Health; 2020;48(92
6. Nagai M, Oikawa M, Tamura T, Egami Y, Fujita N: Can we apply lessons learned from Ebola experience in West Africa for COVID-19 in lower income countries? Global Health & Medicine; 2020; 2(2):140-141
7. Nagai M, Bellizzi S, Murray J, Kitong J, Cabral E, Howard S.: Opportunities lost: Barriers to increasing the use of effective contraception in the Philippines. PLoS ONE ;2019: 14(7): e0218187.
8. Xu T, Tomokawa S, Gregorio ER Jr, Mannava P, Nagai M, Sobel H. School-based interventions to promote adolescent health: A systematic review in low- and middle-income countries of WHO Western Pacific Region. PLoS One;2020 ;15(3): e0230046
9. COVID-19 Research Prioritization Group on MNCAH.: Global research priorities on COVID-19 for maternal, newborn, child and adolescent health. J Glob Health 2021;11:05026
10. Honda A, Krucien N, Ryan M, Diouf I, Salla M, Nagai M, Fujita N: For more than money: willingness of healthprofessionals to stay in remote Senegal. Human Resources for Health; 2019; 17 (28)
11. Bellizzi S, Mannava P, Nagai M, Sobel H.: Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries. Contraception. 2019; 101(1).
12. Zhang L, Tao Y, Woodring J, Rattana K, Sovannarith S, Rathavy T, Cheang K, Hossain S, Ferradini L, Deng S, Sokun C, Samnang C, Nagai M, Ru Lo Y, Ishikawa N. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation. International Journal of Epidemiology;2019: 48(4)
13. Kojo T, Nagai M, Salla M, Diouf I, Fujita N: Retention of qualified health professionals in rural areas: a case control study. Africa Health; 2018; 40 (4); 21-25
14. Woodring J, Ishikawa N, Nagai M, et al.: Integrating HIV, hepatitis B and syphilis screening and treatment through the maternal, newborn and child health platform to reach global elimination targets. WPSAR;2017; 8(4)
15. Nagai M, Fujita N, IS Diouf, M Salla: Retention of qualified health workers in rural Senegal: lessons learned from a qualitative study. Rural and Remote Health; 2017;4149
16. Fujita N, Nagai M, et al.: The role of a network of human resources for health managers in supporting leadership for health systems strengthening in Francophone African countries. Health Systems & Reform; 2016
17. Matsuoka S, Obara H, Nagai M, Murakami H, Chan Lon R. Performance-based financing with GAVI health system strengthening funding in rural Cambodia: a brief assessment of the impact. Health Policy and Planning; 2013; 29(4);456-465.
18. Kitamura T, Obara H, Takashima Y, Takahashi K, Inaoka K, Mari Nagai M, Endo H, Jimba M, Sugiura Y . World Health Assembly Agendas and trends of international health issues for the last 43 years: Analysis of World Health Assembly Agendas between 1970 and 2012. Health Policy; 2013; 110: 198-206.
19. Fujita N, Zwi A, Nagai M, Akashi H. A comprehensive framework for human resources for health system development in fragile and post-conflict states. PLOS Med 2011, 8(12): e1001146.
20. Nagai M, Karunakara U, Rowley E, Burnham G. Violence against refugees, non-refugees and host populationsin southern Sudan and northern Uganda. Global Public Health 2008;3(3):249-270.
21. Nagai M, Sandirasegaram A, Okamotoa M, Kita E, Aoyama A. Reconstruction of health service systems in the post-conflict Northern Province in Sri Lanka. Health Policy 2007; 83: 84-93.

Book

1. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of Accelerating the Equitable Deployment of and Access to Innovations. Geneva, 20200
2. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of the wambo.org pilot for non-Global Fund financed orders. Geneva, 2022
3. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of the Global Fund’s Performance in Challenging Operating Environments (COE). Geneva, 2022
4. World Health Organization Department of Sexual and Reproductive Health and Research (WHO/SRH) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge SUCCESS. Family Planning: A Global Handbook for Providers (2022 update). Baltimore and Geneva: CCP and WHO; 2022.
5. Global Fund. Technical Evaluation Reference Group. Thematic Review of Tuberculosis Prevention. Geneva, 2022
6. Global Fund. Technical Evaluation Reference Group. Thematic Review of Strategic Initiatives. Geneva, 2022
7. Global Fund. Technical Evaluation Reference Group. Thematic Review of Multi-Country Catalytic Investment Grants. Geneva, 2022
8. Global Fund. Technical Evaluation Reference Group. Thematic Review of Global Heath Security (Pandemic Preparedness and Response) – Secretariat-led with TERG oversight. Geneva, 2022
9. Global Fund. Technical Evaluation Reference Group. Prospective Country Evaluation Extension Synthesis Report. Geneva, 2022
10. Global Fund. Technical Evaluation Reference Group. Thematic Review of HIV Primary prevention. Geneva, 2021
11. Global Fund. Technical Evaluation Reference Group Position Paper: Prospective Country Evaluations. Geneva, 2021
12. Global Fund. Technical Evaluation Reference Group. Prospective Country Evaluations Synthesis Report 2021. Geneva, 2021
13. Global Fund. Technical Evaluation Reference Group. Thematic Review on the Role of the Private Sector in Program Delivery. Geneva, 2021
14. World Health Organization. WHO recommendation on uterine balloon tamponade for the treatment ofpostpartum hemorrhage. Geneva. 2021.
15. World Health Organization. Regional Office for the Western Pacific. Meeting Report for the virtual Expert Consultation on Viral Hepatitis Elimination in the Western Pacific Region. 2020.
16. Global Fund. Technical Evaluation Reference Group Position Paper: Strategic Review 2020. Geneva. 2020
17. World Health Organization. WHO recommendation on routes of oxytocin administration for the prevention of postpartum hemorrhage after vaginal birth. Geneva. 2020
18. World Health Organization. WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta. Geneva. 2020
19. World Health Organization. WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum hemorrhage. Geneva. 2020
20. Global Fund. Thematic Review on Sustainability, Transition and Co-Financing Policy. Geneva. 2020
21. Global Fund. Thematic Review of Marketing Shaping Strategy (Mid-Term). Geneva. 2019
22. Global Fund. Thematic review of the Global Fund country level technical support partnership model. Geneva. 2019
23. Global Fund. Thematic review of resilient and sustainable systems for health. Geneva. 2019
24. World Health Organization. Contraceptive eligibility for women at high risk of HIV. Guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. Geneva. 2019
25. World Health Organization. WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections. Geneva. 2018
26. World Health Organization. WHO recommendations: Intrapartum care for a positive pregnancy experience (2018).
27. World Health Organization. Regional Office for the Western Pacific. Introducing and sustaining EENC in hospitals: kangaroo mother care for pre-term and low-birthweight infants. (Early Essential Newborn Care, Module 4). (2018).
28. World Health Organization. Regional Office for the Western Pacific. Second biennial progress report 2016- 2017. (2018)
29. Health Organization. Regional Office for the Western Pacific. Maternal Health Care: Policies, Technical Standards and Service Accessibility in Eight Countries in the Western Pacific Region (2018)
30. World Health Organization. Regional Office for the Western Pacific. Prevent unwanted pregnancy: An infographic on the most effective types of contraception (2018)
31. World Health Organization. Regional Office for the Western Pacific. Annual implementation review and planning guide (Early Essential Newborn Care, Module 1). (2018).
32. World Health Organization. Regional Office for the Western Pacific. Prevent unwanted pregnancy: Abortion in the Western Pacific Region. Infographics (2017)
33. World Health Organization. Regional Office for the Western Pacific. Papua New Guinea : actions for scaling up long-acting reversible contraception
34. World Health Organization. Regional Office for the Western Pacific. Cambodia : Identifying actions for scaling up long-acting reversible contraception
35. World Health Organization. Regional Office for the Western Pacific. Expert consultation on triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in the Western Pacific (2017)
36. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience (2016). Name is mentioned in the document
37. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division (2016).
38. Office for the Western Pacific. First biennial progress report: action plan for healthy newborn infants in the Western Pacific Region (2014-2020) (2016)
39. World Health Organization. Regional Office for the Western Pacific. Introducing and sustaining EENC in hospitals: Routine childbirth and newborn care (2016)
40. World Health Organization. Regional Office for the Western Pacific. Coaching guide for the first embrace: facilitator’s guide (Early Essential Newborn Care) (2016)